A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India

Trial Profile

A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Dec 2016

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Acronyms LEAD-IN
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 04 Mar 2013 New source identified and integrated (Clinical Trials Registry - India, CTRI2010-091-001280).
    • 10 May 2012 Actual patient number is 1386 according to ClinicalTrials.gov.
    • 10 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top